These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37353867)

  • 1. The effect of TB patient delay on loss to follow-up in Portugal.
    Marques J; Rocha JV; Soares P; Leite A; Duarte R; Nunes C
    Int J Tuberc Lung Dis; 2023 Jul; 27(7):537-542. PubMed ID: 37353867
    [No Abstract]   [Full Text] [Related]  

  • 2. Why does it take so long? The reasons behind tuberculosis treatment delay in Portugal.
    Zão I; Ribeiro AI; Apolinário D; Duarte R
    Pulmonology; 2019; 25(4):215-222. PubMed ID: 30930122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
    Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
    Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India.
    Mishra P; Sharma RK; Yadav R; Rao VG; Nigam S; Lingala MA; Bhat J
    PLoS One; 2021; 16(12):e0261152. PubMed ID: 34941885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
    Mann TN; Davis JH; Dyers R
    S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the role of symptom valorisation in tuberculosis patient delay in urban areas in Portugal.
    de Morais M; Sousa S; Marques J; Moniz M; Duarte R; Leite A; Soares P;
    BMC Public Health; 2023 Dec; 23(1):2421. PubMed ID: 38053129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India.
    Zhou TJ; Lakshminarayanan S; Sarkar S; Knudsen S; Horsburgh CR; Muthaiah M; Kan CK; Salgame P; Ellner JJ; Roy G; Jenkins HE; Hochberg NS
    Am J Trop Med Hyg; 2020 Sep; 103(3):1050-1056. PubMed ID: 32618243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania.
    Sariah A; Rugemalila J; Protas J; Aris E; Siril H; Tarimo E; Urassa D
    BMC Public Health; 2019 Aug; 19(1):1172. PubMed ID: 31455306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.